Amedisys Inc (AMED) 14.50 $AMED
Q1 Loss Wider than Expected at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 10:20AM CDT
Amedisys Inc. (AMED) recorded an adjusted loss from continuing operations of 7 cents per share in the first quarter of 2014.
Amedisys Reports First Quarter Financial Results
GlobeNewswire - Thu May 08, 6:08AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2014.
Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference
GlobeNewswire - Wed May 07, 3:48PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading healthcare at home companies, today announced that Ronald A. LaBorde, President and Interim Chief Executive Officer, and Dale E. Redman, Interim Chief Financial Officer, will present at the 2014 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2014.
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders
at The Street - Mon May 05, 9:15AM CDT
Stocks with insider trader activity include ANIK, TRLA and AMED
Amedisys Announces First Quarter Earnings Release and Conference Call Date
GlobeNewswire - Fri Apr 25, 12:15PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the first quarter ended on March 31, 2014 on Thursday, May 8, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
Amedisys Home Health Companies Agree to Pay $150 Million to Resolve False Claims Act Allegations
M2 - Thu Apr 24, 2:39AM CDT
Amedisys Inc. and its affiliates (Amedisys) have agreed to pay $150 million to the federal government to resolve allegations that they violated the False Claims Act by submitting false home healthcare billings to the Medicare program, the Department of Justice announced today. Amedisys, a Louisiana-based for-profit company, is one of the nation's largest providers of home health services and operates in 37 states, the District of Columbia and Puerto Rico.
Whistle Blowers Make Amedisys Pay $150 Million to Settle Medicare Fraud Cases
PRWeb - Wed Apr 23, 7:16PM CDT
Amedisys, Inc. (Amedisys) has agreed to pay $150 million to the federal government to settle claims for violating the false claims act and anti-kickback laws through "improper financial relationships and false billing" according to Daniel R. Levinson, Inspector General for the U.S. Department of Health and Human Services.
Amedisys, Inc. Settles Civil False Claims Act Liabilities for $150 Million
PR Newswire - Wed Apr 23, 4:05PM CDT
The United States Department of Justice and several whistleblowers have reached an agreement with Louisiana based home healthcare provider Amedisys, Inc. ("Amedisys"
to resolve civil fraud liabilities under the Federal False Claims Act ("FCA" for $150 million. In addition to paying a $150 million civil settlement, Amedisys will be bound by a Corporate Integrity Agreement ("CIA" with the Office of Inspector General of the United States Department of Health and Human Services ("OIG-HHS". This settlement is, by far, the largest home healthcare settlement in the history of the FCA, and concludes multiple whistleblower suits, including one brought by CAF Partners, represented by Suzanne Durrell of Durrell Law Office and Robert M. Thomas, Jr. of Thomas and Associates, affiliates of the Whistleblower Law Collaborative, and Tavy Deming and Emily Lambert of Kenney & McCafferty.
Amedisys Finalizes Settlement Agreement With Government
GlobeNewswire - Wed Apr 23, 2:30PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that the company has finalized its previously announced settlement to bring to an end the civil investigation brought by the U.S. Department of Justice ("DOJ".
Feds: Amedisys paying $150 million settlement
AP - Wed Apr 23, 2:22PM CDT
NEW ORLEANS (AP) — Amedisys Inc., a Baton Rouge-based home health company, will pay $150 million to resolve allegations that it inflated Medicare billings and had improper financial relationships with referring physicians, the U.S. Department of Justice said Wednesday.
Amedisys Announces Care Center Closures and Consolidations
GlobeNewswire - Fri Mar 28, 4:30PM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today announced that it will be closing 29 care centers (23 home health and six hospice) and consolidating another 25 care centers (21 home health and four hospice) with care centers servicing the same markets.
Coverage Initiated on Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 9:30AM CDT
On Mar 27, 2014, we initiated coverage on Amedisys.
Amedisys Expands Its Board of Directors with Appointment of KKR's Nathaniel M. Zilkha
Business Wire - Thu Mar 27, 6:00AM CDT
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced the appointment of Nathaniel M. Zilkha to the Company's Board of Directors. Mr. Zilkha is a Member of the general partner of KKR & Co. L.P. (together with its affiliates, "KKR" and serves as Head of KKR's credit platform and as its Global Co-Head of Special Situations. With this addition, the Company's Board now comprises seven directors.
Amedisys Down to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 6:15PM CDT
On Mar 15, 2014, Zacks Investment Research downgraded Amedisys to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
Amedisys Announces Appointment of Dale E. Redman as Interim Chief Financial Officer
Business Wire - Wed Mar 19, 8:30AM CDT
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced the appointment of Dale E. Redman to the position of Interim Chief Financial Officer. Mr. Redman served as the Company's Chief Financial Officer from February 2007 through December 2011, and retired from the Company as its Executive Vice President of Finance in February 2012.
Q4 Loss Widens at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:00AM CDT
Amedisys recorded adjusted loss from continuing operations per share of 5 cents in the fourth quarter of 2013.
Amedisys Reports Fourth Quarter Financial Results
Business Wire - Wed Mar 12, 6:00AM CDT
Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the fourth quarter and year ended December 31, 2013.
Downgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Tue Mar 11, 7:07AM CDT
Amedisys (NASDAQ:AMED) was downgraded from Outperform to Perform at Oppenheimer today. The stock closed yesterday at $16.20 on volume of 205,000 shares, below average daily volume of 244,000. Based on a current price of $16.20, Amedisys is currently 35.6% above its average consensus analyst price target of $10.43. The stock should discover initial support at its 50-day moving average (MA) of $15.51 and subsequent support at its 200-day MA of $15.12.
Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date
Business Wire - Wed Mar 05, 10:00AM CST
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the fourth quarter ended on December 31, 2013 on Wednesday, March 12, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
Amedisys Chairman & CEO William Borne Steps Down
Business Wire - Mon Feb 24, 7:31AM CST
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced that William (Bill) F. Borne, Chief Executive Officer and Chairman of the Board, has stepped down as CEO, Chairman and Director. In recognition of his 33 years of service since founding the Company in 1982, the Board of Directors has named Mr. Borne Chairman Emeritus.
Q1 Loss Wider than Expected at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon May 12, 10:20AM CDT
Amedisys Inc. (AMED) recorded an adjusted loss from continuing operations of 7 cents per share in the first quarter of 2014.
Amedisys Reports First Quarter Financial Results
GlobeNewswire - Thu May 08, 6:08AM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2014.
Amedisys to Present at the Bank of America Merrill Lynch Health Care Conference
GlobeNewswire - Wed May 07, 3:48PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading healthcare at home companies, today announced that Ronald A. LaBorde, President and Interim Chief Executive Officer, and Dale E. Redman, Interim Chief Financial Officer, will present at the 2014 Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2014.
Insider Trading Alert - ANIK, TRLA And AMED Traded By Insiders
at The Street - Mon May 05, 9:15AM CDT
Stocks with insider trader activity include ANIK, TRLA and AMED
Amedisys Announces First Quarter Earnings Release and Conference Call Date
GlobeNewswire - Fri Apr 25, 12:15PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the first quarter ended on March 31, 2014 on Thursday, May 8, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
Amedisys Home Health Companies Agree to Pay $150 Million to Resolve False Claims Act Allegations
M2 - Thu Apr 24, 2:39AM CDT
Amedisys Inc. and its affiliates (Amedisys) have agreed to pay $150 million to the federal government to resolve allegations that they violated the False Claims Act by submitting false home healthcare billings to the Medicare program, the Department of Justice announced today. Amedisys, a Louisiana-based for-profit company, is one of the nation's largest providers of home health services and operates in 37 states, the District of Columbia and Puerto Rico.
Whistle Blowers Make Amedisys Pay $150 Million to Settle Medicare Fraud Cases
PRWeb - Wed Apr 23, 7:16PM CDT
Amedisys, Inc. (Amedisys) has agreed to pay $150 million to the federal government to settle claims for violating the false claims act and anti-kickback laws through "improper financial relationships and false billing" according to Daniel R. Levinson, Inspector General for the U.S. Department of Health and Human Services.
Amedisys, Inc. Settles Civil False Claims Act Liabilities for $150 Million
PR Newswire - Wed Apr 23, 4:05PM CDT
The United States Department of Justice and several whistleblowers have reached an agreement with Louisiana based home healthcare provider Amedisys, Inc. ("Amedisys"
to resolve civil fraud liabilities under the Federal False Claims Act ("FCA" for $150 million. In addition to paying a $150 million civil settlement, Amedisys will be bound by a Corporate Integrity Agreement ("CIA" with the Office of Inspector General of the United States Department of Health and Human Services ("OIG-HHS". This settlement is, by far, the largest home healthcare settlement in the history of the FCA, and concludes multiple whistleblower suits, including one brought by CAF Partners, represented by Suzanne Durrell of Durrell Law Office and Robert M. Thomas, Jr. of Thomas and Associates, affiliates of the Whistleblower Law Collaborative, and Tavy Deming and Emily Lambert of Kenney & McCafferty. Amedisys Finalizes Settlement Agreement With Government
GlobeNewswire - Wed Apr 23, 2:30PM CDT
Amedisys, Inc. (Nasdaq:AMED), one of America's leading home health and hospice care companies, announced today that the company has finalized its previously announced settlement to bring to an end the civil investigation brought by the U.S. Department of Justice ("DOJ"
. Feds: Amedisys paying $150 million settlement
AP - Wed Apr 23, 2:22PM CDT
NEW ORLEANS (AP) — Amedisys Inc., a Baton Rouge-based home health company, will pay $150 million to resolve allegations that it inflated Medicare billings and had improper financial relationships with referring physicians, the U.S. Department of Justice said Wednesday.
Amedisys Announces Care Center Closures and Consolidations
GlobeNewswire - Fri Mar 28, 4:30PM CDT
Amedisys, Inc. (Nasdaq:AMED), a leading home health and hospice company, today announced that it will be closing 29 care centers (23 home health and six hospice) and consolidating another 25 care centers (21 home health and four hospice) with care centers servicing the same markets.
Coverage Initiated on Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 28, 9:30AM CDT
On Mar 27, 2014, we initiated coverage on Amedisys.
Amedisys Expands Its Board of Directors with Appointment of KKR's Nathaniel M. Zilkha
Business Wire - Thu Mar 27, 6:00AM CDT
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced the appointment of Nathaniel M. Zilkha to the Company's Board of Directors. Mr. Zilkha is a Member of the general partner of KKR & Co. L.P. (together with its affiliates, "KKR"
and serves as Head of KKR's credit platform and as its Global Co-Head of Special Situations. With this addition, the Company's Board now comprises seven directors. Amedisys Down to Hold - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 6:15PM CDT
On Mar 15, 2014, Zacks Investment Research downgraded Amedisys to a Zacks Rank #3 (Hold) from a Zacks Rank #2 (Buy).
Amedisys Announces Appointment of Dale E. Redman as Interim Chief Financial Officer
Business Wire - Wed Mar 19, 8:30AM CDT
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced the appointment of Dale E. Redman to the position of Interim Chief Financial Officer. Mr. Redman served as the Company's Chief Financial Officer from February 2007 through December 2011, and retired from the Company as its Executive Vice President of Finance in February 2012.
Q4 Loss Widens at Amedisys - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 13, 8:00AM CDT
Amedisys recorded adjusted loss from continuing operations per share of 5 cents in the fourth quarter of 2013.
Amedisys Reports Fourth Quarter Financial Results
Business Wire - Wed Mar 12, 6:00AM CDT
Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the fourth quarter and year ended December 31, 2013.
Downgrade Alert for Amedisys (AMED)
Comtex SmarTrend(R) - Tue Mar 11, 7:07AM CDT
Amedisys (NASDAQ:AMED) was downgraded from Outperform to Perform at Oppenheimer today. The stock closed yesterday at $16.20 on volume of 205,000 shares, below average daily volume of 244,000. Based on a current price of $16.20, Amedisys is currently 35.6% above its average consensus analyst price target of $10.43. The stock should discover initial support at its 50-day moving average (MA) of $15.51 and subsequent support at its 200-day MA of $15.12.
Amedisys Announces Fourth Quarter Earnings Release and Conference Call Date
Business Wire - Wed Mar 05, 10:00AM CST
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, announced today that it will host a conference call to discuss results for the fourth quarter ended on December 31, 2013 on Wednesday, March 12, 2014 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The Company will issue its quarterly earnings release prior to hosting the conference call.
Amedisys Chairman & CEO William Borne Steps Down
Business Wire - Mon Feb 24, 7:31AM CST
Amedisys, Inc. (NASDAQ: AMED), one of America's leading home health and hospice care companies, today announced that William (Bill) F. Borne, Chief Executive Officer and Chairman of the Board, has stepped down as CEO, Chairman and Director. In recognition of his 33 years of service since founding the Company in 1982, the Board of Directors has named Mr. Borne Chairman Emeritus.
